Cargando…
Oncogenic Functions and Therapeutic Targeting of EphA2 in Cancer
More than twenty-five years of research and pre-clinical validation have defined EphA2 receptor tyrosine kinase as a promising molecular target for clinical translation in cancer treatment. Molecular, genetic, biochemical, and pharmacological targeting strategies have been extensively tested in vitr...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035212/ https://www.ncbi.nlm.nih.gov/pubmed/33686241 http://dx.doi.org/10.1038/s41388-021-01714-8 |